# Kirilys Therapeutics

**Canonical:** https://apis.io/providers/kirilys-therapeutics/  
**Website:** https://kirilystx.com/  
**APIs profiled:** 0

Kirilys Therapeutics is a multi-asset precision oncology company developing targeted therapeutic treatments for cancer patients. Led by co-founder and CEO BT Slingsby, MD, PhD, MPH, the company is building a pipeline of precision medicines and is backed by Catalys Pacific, Lightspeed Venture Partners, and UBE. Kirilys was surfaced as a portfolio company of Lightspeed Venture Partners and added to the API Evangelist network. As a clinical-stage biotech, Kirilys publishes a corporate marketing website (company, news, and contact pages) but exposes no public developer API, SDK, documentation, or machine discovery surface at this time.

## Kin Score — 10.5 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 10.5).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Kirilys Therapeutics Domain Security** — TLSv1.3

## Tags

Company, Therapeutics, Oncology, Biotechnology, Pharmaceuticals, Precision Medicine, Healthcare, Drug Development

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/kirilys-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.